{
    "url": "https://en.wikipedia.org/wiki/Perflubron",
    "title": "Perflubron",
    "summary": "Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography. It was approved for this use in the United States by the Food and Drug Administration in 1993.",
    "content": "Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography. It was approved for this use in the United States by the Food and Drug Administration in 1993.\n\n\n== Experimental research ==\n\nPerflubron has also been tested experimentally for use in liquid breathing in premature infants with respiratory distress.\n\n\n== References ==",
    "links": [
        "ATC code V08",
        "Acetrizoic acid",
        "Adipiodone",
        "Anatomical Therapeutic Chemical Classification System",
        "Barium sulfate",
        "Boiling point",
        "CAS Registry Number",
        "Calcium iopodate",
        "ChEMBL",
        "ChemSpider",
        "Chemical formula",
        "Clinical trial",
        "CompTox Chemicals Dashboard",
        "Computer tomography",
        "Contrast-enhanced ultrasound",
        "Contrast medium",
        "Density",
        "Diatrizoic acid",
        "Diodone",
        "Doi (identifier)",
        "ECHA InfoCard",
        "Ethyl ester",
        "Fatty acid",
        "Ferric ammonium citrate",
        "Ferristene",
        "Ferumoxsil",
        "Food and Drug Administration",
        "Gadobenic acid",
        "Gadobutrol",
        "Gadodiamide",
        "Gadofosveset",
        "Gadolinium",
        "Gadolinium-based MRI contrast agent",
        "Gadopentetic acid",
        "Gadoteric acid",
        "Gadoteridol",
        "Gadoversetamide",
        "Gadoxetic acid",
        "Galactose",
        "Human serum albumin",
        "IUPAC nomenclature of chemistry",
        "International Chemical Identifier",
        "International Nonproprietary Name",
        "Iobenzamic acid",
        "Iobitridol",
        "Iocarmic acid",
        "Iocetamic acid",
        "Iodamide",
        "Iodixanol",
        "Iodoxamic acid",
        "Iofendylate",
        "Ioglicic acid",
        "Ioglycamic acid",
        "Iohexol",
        "Iomeprol",
        "Iopamidol",
        "Iopanoic acid",
        "Iopentol",
        "Iopromide",
        "Iopydol",
        "Iotalamic acid",
        "Iotrolan",
        "Iotroxic acid",
        "Ioversol",
        "Ioxaglic acid",
        "Ioxilan",
        "Ioxitalamic acid",
        "Iron oxide",
        "JSmol",
        "Lipiodol",
        "Liquid breathing",
        "List of withdrawn drugs",
        "MRI contrast agent",
        "Magnetic resonance imaging",
        "Mangafodipir",
        "Melting point",
        "Methiodal",
        "Metrizamide",
        "Metrizoic acid",
        "Microparticle",
        "Microsphere",
        "Molar mass",
        "Nanoparticle",
        "PMID (identifier)",
        "Paramagnetic",
        "Perflenapent",
        "Perflubron (data page)",
        "Pharmacology",
        "Phases of clinical research",
        "Phospholipid",
        "Propyliodone",
        "PubChem",
        "Radiocontrast",
        "Simplified molecular-input line-entry system",
        "Sodium iopodate",
        "Sonography",
        "Sulfur hexafluoride",
        "Superparamagnetism",
        "Tyropanoic acid",
        "Unique Ingredient Identifier",
        "United States Adopted Name",
        "WHO Model List of Essential Medicines"
    ]
}